New mouthwash may render cavities a thing of the past
(Medical Xpress) -- A new mouthwash developed by a microbiologist at the UCLA School of Dentistry is highly successful in targeting the harmful Streptococcus mutans bacteria that is the principal cause tooth decay and cavities.
Health
Nov 16, 2011 |
4.6 / 5 (13) |
33
|
'Micro'-chemo and cancer pill combo tested in liver cancer patients
A combination of an oral drug, called sorafenib, and a method for injecting microbeads of chemotherapy directly into tumors has been proven safe for liver cancer patients and may improve outcomes for those who have these ...
Cancer
Sep 30, 2011 |
5 / 5 (3) |
0
|
Heart hormone helps shape fat metabolism
It's well known that exercising reduces body weight because it draws on fat stores that muscle can burn as fuel. But a new study at Sanford-Burnham Medical Research Institute (Sanford-Burnham) suggests that ...
Medical research
Feb 06, 2012 |
5 / 5 (3) |
0
|
Firefly protein lights up degenerating muscles, aiding muscular-dystrophy research
Stanford University School of Medicine scientists have created a mouse model of muscular dystrophy in which degenerating muscle tissue gives off visible light. The observed luminescence occurs only in damaged muscle tissue ...
Medical research
Apr 24, 2013 |
5 / 5 (3) |
0
|
Cause and potential treatment found for cancer drug's kidney toxicity
Scientists may have a way to make the powerful cancer drug cisplatin less toxic to the kidneys and more effective against some cancers.
Cancer
Jun 02, 2011 |
4.7 / 5 (3) |
0
|
New Stanford regimen frees kidney-transplant patients from dependency on immunosuppresant drugs
Investigators at the Stanford University School of Medicine have developed a novel protocol that allows kidney-transplant recipients to jettison their indispensable immune-suppressing drugs. The protocol could also spell ...
Medications
Oct 05, 2011 |
4.7 / 5 (3) |
0
First study on long-term cognitive effects of breast cancer CMF chemotherapy finds subtle impairment
Dutch investigators have reported that women who received CMF chemotherapy (a combination regimen including the drugs cyclophosphamide, methotrexate, and 5-fluorouracil) for breast cancer between 1976 and 1995 scored worse ...
Cancer
Feb 27, 2012 |
4.7 / 5 (3) |
0
|
Commentary: Drug companies must report clinical trial results, even when they won't lead to a product
Drug companies sponsoring human trials of possible new medications have ethical responsibilities to study participants and to science to disclose the results of their clinical research -- even when product development is ...
Medications
Sep 28, 2011 |
5 / 5 (2) |
1
|
Dirty packing plant blamed for killer cantaloupes
A dirty packing facility at a Colorado farm was the likely source of an outbreak of listeria in cantaloupes that killed 25 people in the US since August, health authorities said Wednesday.
Diseases, Conditions, Syndromes
Oct 19, 2011 |
5 / 5 (2) |
0
RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer
Over 17,000 patients will have been diagnosed with locally-advanced pancreatic cancer in the United States in 2011. Surgery is not a treatment option for these patients whose tumor has grown beyond the pancreas to surrounding ...
Cancer
Dec 14, 2011 |
5 / 5 (2) |
0
New melanoma drug Zelboraf nearly doubles survival in majority of patients
Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.
Cancer
Feb 22, 2012 |
5 / 5 (2) |
0
|
Researchers discover drug target for stimulating recovery from stroke
Investigators at the Stanford University School of Medicine have shown that removing a matched set of molecules that typically help to regulate the brain's capacity for forming and eliminating connections between nerve cells ...
Neuroscience
Mar 21, 2012 |
5 / 5 (2) |
0
|
CU Cancer Center opens phase I clinical trial of anti-cancer stem cell agent OMP-54F28
The University of Colorado Cancer Center, together with other participating academic medical centers, recently opened a phase I human clinical trial of the drug OMP-54F28 in patients with advanced solid tumor cancers. OMP-54F28, ...
Cancer
Oct 03, 2012 |
5 / 5 (2) |
0
Research identifies targeted molecular therapy for untreatable NF1 tumors
Researchers conducting a preclinical study in mice successfully used targeted molecular therapy to block mostly untreatable nerve tumors that develop in people with the genetic disorder Neurofibromatosis 1 (NF1).
Cancer
Dec 10, 2012 |
5 / 5 (2) |
0
|
A better bone marrow transplant: Preventing graft-versus-host disease
Bone marrow transplant is a key treatment for patients with leukemia, lymphoma, multiple myeloma and other blood disorders.
Medical research
Mar 01, 2013 |
5 / 5 (2) |
0
|
